Janet E. Davis

808 total citations
17 papers, 701 citations indexed

About

Janet E. Davis is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Janet E. Davis has authored 17 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Janet E. Davis's work include T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Melanoma and MAPK Pathways (4 papers). Janet E. Davis is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Melanoma and MAPK Pathways (4 papers). Janet E. Davis collaborates with scholars based in United States, Norway and Sweden. Janet E. Davis's co-authors include Peter Cresswell, Ann E. Berger, John J. Siekierka, Peter Schäfer, Scott Wadsworth, Druie Cavender, Robert Wondergem, Gilbert C. Olini, Liang Wang and Michael P. Wachter and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Janet E. Davis

16 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet E. Davis United States 13 322 286 132 88 87 17 701
Janey N. Parsons United States 9 179 0.6× 384 1.3× 126 1.0× 58 0.7× 48 0.6× 10 691
Marianne Scheel Fjording Denmark 11 238 0.7× 303 1.1× 125 0.9× 49 0.6× 45 0.5× 17 610
Z. Mishal France 19 238 0.7× 487 1.7× 157 1.2× 20 0.2× 84 1.0× 32 922
Hollis R. Williams United States 12 146 0.5× 337 1.2× 155 1.2× 71 0.8× 46 0.5× 15 810
Shigeru Ushiyama Japan 11 185 0.6× 328 1.1× 110 0.8× 80 0.9× 75 0.9× 33 757
Paul A. Morse United States 13 145 0.5× 458 1.6× 136 1.0× 38 0.4× 84 1.0× 24 756
Seymour I. Schlager United States 19 340 1.1× 353 1.2× 75 0.6× 23 0.3× 73 0.8× 48 730
J B Stoudemire United States 11 139 0.4× 251 0.9× 39 0.3× 31 0.4× 87 1.0× 14 564
T W Strickland United States 10 174 0.5× 443 1.5× 57 0.4× 72 0.8× 112 1.3× 10 871
Rudolf Mihalik Hungary 16 205 0.6× 535 1.9× 206 1.6× 33 0.4× 36 0.4× 58 846

Countries citing papers authored by Janet E. Davis

Since Specialization
Citations

This map shows the geographic impact of Janet E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet E. Davis more than expected).

Fields of papers citing papers by Janet E. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet E. Davis. The network helps show where Janet E. Davis may publish in the future.

Co-authorship network of co-authors of Janet E. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Janet E. Davis. A scholar is included among the top collaborators of Janet E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet E. Davis. Janet E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Davis, Janet E., et al.. (2018). Pathophysiological mechanisms for the development of gestational diabetes insipidus. 1(2). 1 indexed citations
2.
Berman, Dora M., Over Cabrera, Norman M. Kenyon, et al.. (2007). Interference with Tissue Factor Prolongs Intrahepatic Islet Allograft Survival in a Nonhuman Primate Marginal Mass Model. Transplantation. 84(3). 308–315. 66 indexed citations
3.
Li, Jian, Janet E. Davis, Jill M. Carton, et al.. (2006). Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody. International Immunopharmacology. 6(6). 880–891. 15 indexed citations
4.
Wadsworth, Scott, Druie Cavender, Scott A. Beers, et al.. (1999). RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase. Journal of Pharmacology and Experimental Therapeutics. 291(2). 680–687. 133 indexed citations
5.
Schäfer, Peter, Liwen Wang, Scott Wadsworth, Janet E. Davis, & John J. Siekierka. (1999). T Cell Activation Signals Up-Regulate p38 Mitogen-Activated Protein Kinase Activity and Induce TNF-α Production in a Manner Distinct from LPS Activation of Monocytes. The Journal of Immunology. 162(2). 659–668. 54 indexed citations
6.
Schäfer, Peter, Liang Wang, Scott Wadsworth, Janet E. Davis, & John J. Siekierka. (1999). T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes.. PubMed. 162(2). 659–68. 64 indexed citations
7.
Davis, Janet E., John H. Dodd, Crafford A. Harris, et al.. (1998). The development of novel and selective p56lck tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(18). 2489–2494. 7 indexed citations
8.
Henry, James R., Kenneth C. Rupert, John H. Dodd, et al.. (1998). 6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1H-pyrrolo[2,3-b]pyridine (RWJ 68354):  A Potent and Selective p38 Kinase Inhibitor. Journal of Medicinal Chemistry. 41(22). 4196–4198. 59 indexed citations
9.
Beers, Scott A., Elizabeth A. Malloy, Wei Wu, et al.. (1997). Nitroarylhydroxymethylphosphonic acids as inhibitors of CD45. Bioorganic & Medicinal Chemistry. 5(12). 2203–2211. 19 indexed citations
10.
Wondergem, Robert & Janet E. Davis. (1994). Ethanol Increases Hepatocyte Water Volume. Alcoholism Clinical and Experimental Research. 18(5). 1230–1236. 34 indexed citations
11.
Cresswell, Peter, Janice S. Blum, Janet E. Davis, & Michael S. Marks. (1990). Transport and expression of HLA class-II glycoproteins. Immunologic Research. 9(3). 190–199. 4 indexed citations
12.
Davis, Janet E. & Peter Cresswell. (1990). Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique.. The Journal of Immunology. 144(3). 990–997. 58 indexed citations
13.
Davis, Janet E., et al.. (1987). Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency.. Journal of Clinical Investigation. 80(4). 998–1008. 7 indexed citations
14.
Berger, Ann E., Janet E. Davis, & Peter Cresswell. (1982). Monoclonal Antibody to HLA-A3. Hybridoma. 1(2). 87–90. 104 indexed citations
15.
Berger, Ann E., Janet E. Davis, & Peter Cresswell. (1981). A human leukocyte antigen identified by a monoclonal antibody. Human Immunology. 3(3). 231–245. 43 indexed citations
16.
Davis, Janet E., et al.. (1974). UMP-dependent reduction of UDP-galactose 4-epimerase-NAD+ complex by sodium cyanoborohydride. Biochimica et Biophysica Acta (BBA) - Enzymology. 334(2). 442–447. 15 indexed citations
17.
Davis, Janet E., et al.. (1972). Studies on the Mechanism of Action of Uridine Diphosphate-galactose-4-epimerase. Journal of Biological Chemistry. 247(4). 1339–1342. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026